Based on genetic aberrations of AR or the increased synthesis of androgens (in the tumor microenvironment [TME]) or adrenal androgen precursors, it has been reported that AR expression is increased [50] and that AR signaling is consistent with the castration level of androgens in patients with mCRPC. The gene discussed is AR; the disease is neoplasm.